HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma (Q41050317)

26 September 2017

title

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma (English)

1 reference

26 September 2017

author

Anna Szumera-Cieckiewicz

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ewa Lech-Maranda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Wojciech Młynarski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Tadeusz Robak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

Monika Prochorec-Sobieszek

9 June 2020

series ordinal

object named as

Monika Prochorec-Sobieszek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Dorota Jesionek-Kupnicka

series ordinal

object named as

Dorota Jesionek-Kupnicka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Radzisław Kordek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marcin Bojo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Joanna Jabłońska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

14 December 2015

1 reference

Archivum Immunologiae et Therapiae Experimentalis

26 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

225-240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

The role of classical and non-classical HLA class I antigens in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G: from biology to clinical benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Trogocytosis-based generation of suppressive NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Research on HLA-G: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Human leukocyte antigen-G polymorphism in relation to expression, function, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Biology and functions of human leukocyte antigen-G in health and sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Trogocytic intercellular membrane exchanges among hematological tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G 2012 conference: the 15-year milestone update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: does it have a prognostic value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G expression in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-015-0372-8

10.1007/S00005-015-0372-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667793%20AND%20SRC:MED&resulttype=core&format=json